We have investigated the effects of insulinlike growth factors (IGFs), basic fibroblast growth factor (bFGF), and nerve growth factor (NGF) on DNA synthesis in cultured chromaffin cells from fetal, neonatal, and adult rats by using 5-bromo-2'-deoxyuridine (BrdUrd) pulse labeling for 24 or 48 h and immunocytochemical staining of cell nuclei. After 6 days in culture in the absence ofgrowth factors, nuclear BrdUrd incorporation was detected in 30% of fetal chromafFin cells, 
chromaffn cells. The ED50 value of IGF-I-and IGF-IIstimulated BrdUrd labeling in neonatal chromaffin cells was 0.3 nM and 0.8 nM, respectively. In neonatal and adult chromaffin cells, addition of 1 nM bFGF or 2 nM NGF stimulated nuclear BrdUrd incorporation to approximately the same level as 10 nM IGF-I or IGF-II. However, the response to bFGF or NGF in combination with either IGF-I or IGF-ll was more than additive, indicating that the combined effect of the IGFs and bFGF or NGF is synergistic. The degree of synergism was 2-to 4-fold in neonatal chromaffin cells and 10-to 20-fold in adult chromaffin cells compared with the effect of each growth factor alone. In contrast, the action of bFGF and NGF added together in the absence of IGFs was not synergistic or additive. IGF-II acted also as a survival factor on neonatal chromaftn cells and the cell survival was further improved when bFGF or NGF was added together with IGF-H. In conclusion, we propose that IGF-I and IGF-U act in synergy with bFGF and NGF to stimulate proliferation and survival of chromaffm cells during neonatal growth and adult maintenance of the adrenal medulla. Our findings may have implications for improving the survival of chromaffin cell implants in diseased human brain.
The chromaffin cells of the adrenal medulla are derived from the neural crest and are ontogenetically related to sympathetic neurons. In the rat, chromaffin-cell precursors invade the primordial adrenocortical structure about embryonic day 14 where they differentiate into mature chromaffin cells (1) . Chromaffin-cell division in the rat occurs mainly during fetal and neonatal development, whereas proliferation of adult chromaffmi cells is very low (2) (3) (4) (5) . Little is known about the factors that regulate the growth of chromaffin cells. Postnatally, basic fibroblast growth factor (bFGF) is present in bovine and rat adrenal medulla (6, 7) , and bFGF stimulates the proliferation of neonatal rat chromaffmi cells (8, 9) . It is not known whether nerve growth factor (NGF) is present in the adrenal medulla, but specific high-affinity NGF binding sites have been demonstrated in chromaffnm cells from neonatal rats (10) , and NGF acts as a mitogen on cultured chromaffm cells from neonatal and adult rats (11, 12) . In addition, NGF and bFGF stimulate transdifferentiation of cultured chromaffin cells into a sympathetic neuron-like phenotype and increase cell survival and catecholamine synthesis (8, 9, (13) (14) (15) . In adult rats, chromaffmi-cell replacement decreases after denervation of the adrenal medulla, suggesting that neurogenic stimuli can regulate chromaffmicell proliferation (16) .
Insulin-like growth factor I and II (IGF-I and IGF-II, respectively) act as neurotrophic factors in various parts of the developing and adult nervous system (17) . IGF-II mRNA and immunoreactivity have been demonstrated in adult human and rat adrenal medulla (18) (19) (20) (21) . Human and bovine chromaffmi cells express the IGF-I receptor tyrosine kinase that mediates the action of both IGF-I and IGF-II (22) (23) (24) , and IGF-I stimulates catecholamine synthesis and secretion by cultured bovine chromaffin cells in vitro (22, (25) (26) (27) Assay of Cell Survival. Neonatal chromaffin cells on plastic culture dishes were cultured in medium with 0.4% albumin and N1 supplement without insulin. After 2, 4, or 6 days of culture in the presence of IGF-II, bFGF, or NGF, the cells were washed twice in Hanks' balanced salt solution. Chromaffin cells adhering to the dish were counted in two orthogonal sections of each dish (=5% of the total area) using phase-contrast microscopy. Neonatal chromaffin cells were identified by their characteristic morphology [i.e., phasebright rounded or polygonal cells with a large round nucleus and occasionally bearing processes or being flattened after addition of bFGF or NGF (11, 15, 37) ]. More than 90o of the chromaffin cells adhering to the culture substratum were viable as estimated by nigrosin blue exclusion.
Assay of Neuronal Differentiation. Neonatal chromaffin cells on glass coverslips were cultured in medium with 0.4% albumin and N1 supplement without insulin and exposed to NGF, bFGF, or IGF-II for 6 days. After washing in PBS, the cells were immunostained for tyrosine hydroxylase and examined by immunofluorescence microscopy. pulse-labeled with BrdUrd during the final 48 h in culture. Fig. 1 (Fig. 2) . The concentration of IGF-I and IGF-II giving a half-maximal effect (EC50) was 0.3 nM and 0.8 nM, respectively. Insulin stimulated DNA synthesis with an EC50 value of 1 nM and a lower maximal effect than IGFs. We conclude that IGF-I, IGF-II, and insulin stimulate DNA synthesis in cultured chromaffin cells from fetal, neonatal, and adult rats and exert their mitogenic effect in the physiological concentration range.
Synergistic Effect of IGFs and bFGF or NGF on DNA Synthesis and Proliferation of Chromaffin Cells. bFGF at a maximally stimulating concentration of 1 nM (9) increased the fraction of BrdUrd-labeled neonatal chromaffm cells to the same level of 10% as 10 nM IGF-II after 6 days in culture and pulse labeling with BrdUrd for the final 24 h (Fig. 3A) .
Addition of bFGF plus IGF-II increased the fraction of BrdUrd-labeled cells to 45%, which is significantly higher than an additive effect, indicating that the two growth factors act in synergy. Furthermore, NGF at a maximally stimulating concentration of 2 nM (11) acted synergistically with 10 nM IGF-II in neonatal chromaffmi cells since the BrdUrd incorporation was increased by NGF plus IGF-II to 40% compared with the effect of the two growth factors alone of 20% and 10%. In contrast, the effect of bFGF plus NGF was neither additive nor synergistic.
In adult chromaffin cells, the synergistic effect of bFGF and IGF-II was more pronounced (Fig. 3B ). Upon stimulation with either growth factor alone for 6 days and a final 24-h BrdUrd pulse, these cells showed a very low response of 1% of the cells being labeled with BrdUrd, but in the presence of bFGF plus IGF-II =20% of the adult chromaffin cells had incorporated BrdUrd. The combined effect of NGF and IGF-II on adult chromaffin cells was also clearly synergistic as 10%o of nuclei were BrdUrd-labeled compared with the effect of 1% to each growth factor alone. bFGF and NGF added together in the absence of IGF-II showed no additive or synergistic effect. In both neonatal and adult chromaffin cells, 10 nM IGF-I showed the same synergy with bFGF or NGF as was observed with IGF-II (data not shown).
Measurement of the time course of the effects of IGF-II and bFGF on DNA synthesis in neonatal chromaffin cells showed that the synergistic stimulation of BrdUrd incorporation occurred 2-3 days after the addition of growth factors and reached a maximal level that was constant from 4 to 6 days (Fig. 4) . In adult chromaffin cells, the synergistic stimulation of DNA synthesis by IGF-II and bFGF was seen after 5 days (data not shown).
To assess whether BrdUrd incorporation in DNA is followed by cell division, neonatal chromaffin cells were stimulated 6 days with 10 nM IGF-II plus 1 nM bFGF and pulse-labeled with BrdUrd for 3 h. The cells were either fixed immediately or washed twice to remove BrdUrd and cultured for 2 additional days in the presence of growth factors before fixation. In cultures fixed immediately after the BrdUrd pulse on day 6, >80%o of labeled chromaffin cells were singlets. However, BrdUrd-labeled chromaffin cells were predominantly doublets or quadruplets 2 days after the BrdUrd pulse on day 8 (data not shown). Since the cell density in the cultures was very low, we assume that doublets and quadruplets of BrdUrd-labeled chromaffin cells arise from cell division and not from aggregation. These data suggest that IGF-II-and bFGF-stimulated DNA synthesis is followed by cell division. In conclusion, our data show that IGF-I and IGF-II can interact with bFGF plus NGF to stimulate DNA synthesis and proliferation of neonatal and adult chromaffin cells in a synergistic manner. IGF-fl, bFGF, and NGF Are Survival Factors for Chromaffin Cells. In the absence of growth factors, the number of viable neonatal chromaffin cells attached to the culture dish declined rapidly, reaching 7% of its initial value after 6 days of culture (Fig. 5) . In the presence of 10 nM IGF-II or 1 nM bFGF, the chromaffin cell number declined at a slower rate and after 6 days the percentage ofsurviving cells was 30-40% of the initial cell number. Addition of IGF-II plus bFGF completely prevented the decline in chromaffin cell number after 2-4 days and reversed it to 175% ofthe initial value after 6 days of culture. This effect may be attributed partly to increased cell survival and partly to increased cell proliferation (see Fig. 4 ). Addition of 2 nM NGF alone increased the fraction of surviving chromaffin cells after 6 days to 20%6 (+2%, n = 4) of its initial value, whereas NGF plus IGF-II increased the chromaffin cell number to 105% (±15%, n = 4) after 6 days in culture (data not shown).
Exposure to either NGF or bFGF for 6 days induced neuronal transdifferentiation of 11% (±2%, n = 4) and 2% (+1%, n = 4) of neonatal rat chromaffin cells, respectively, as demonstrated by others (8, 9, (13) (14) (15) . IGF-II alone did not elicit neurite formation beyond basal values (<0.1%). However, the fraction of neurite-bearing cells induced by NGF or bFGF was reduced by IGF-II to 6% (±2%, n = 4) and 0.5% (+0.2%, n = 4), respectively (data not shown). In conclusion, IGF-II acts as a survival factor and mitogen for neonatal chromaffin cells without induction of neuronal differentiation, and the effect ofIGF-II is potentiated by bFGF or NGF.
DISCUSSION
Mitogenic Effect of IGF-I and IGF-JIL In this report we describe the mitogenic effect of IGF-I and IGF-II on chromaffin cells from fetal, neonatal, and adult rats in vitro. We employed a serum-free culture system to avoid interference from IGFs and IGF-binding proteins in serum. The responsiveness to IGF-I and IGF-II differed significantly with the developmental stage, being highest in neonatal and lowest in adult chromaffin cells. The dose-response relationship of IGFs in neonatal chromaffin cells corresponds to that observed in other cell types, and the fact that IGF-I is more potent than IGF-II suggests that the effect is mediated by the IGF-I receptor (41) . The mitogenic effect of insulin on the chromaffin cells may also be mediated by the IGF-I receptor that binds insulin with low affinity (K; 0.1-1 MM). However, the relatively high potency of insulin (ED50 1 nM) and a maximal response that is distinct from that of the IGFs may indicate that insulin is acting through the insulin receptor present on chromaffin cells (23) . (42, 43) . Apart from this difference, activation of the IGF-I, bFGF, and NGF receptors leads to stimulation of phosphatidylinositol 3-kinase and Ras GTP binding (42) (43) (44) (45) (46) (47) , and these signaling molecules may represent the points of convergence in the mitogenic signal pathway.
Previous studies have shown that NGF and bFGF induce an initial mitogenic response in neonatal and adult rat chromaffin cells and rat PC12 cells that is followed by neuronal differentiation and growth arrest (8, 9, 11, 12, 48, 49) , whereas IGF-I and IGF-II stimulate proliferation of PC12 cells only and are not capable of inducing a neuronal phenotype (28, 29) . This is confirmed by ourfinding that IGFs did not induce neuronal differentiation of chromaffin cells in contrast to bFGF and NGF, suggesting that the signals leading to neuronal differentiation are different from those leading to cell division.
Chromaffin Cel Survival. The increased neonatal chromaffin cell number after 2 days in the presence of IGF-II seems mainly to be due to increased cell survival as IGF-IIstimulated proliferation was first seen after 3-4 days. Improved cell viability may in part be a consequence of the actions of IGF-II on cellular metabolism, such as increased glucose and amino acid uptake and stimulation of protein synthesis (41) . The stimulatory effects of bFGF and NGF on chromaffin cell survival in vitro have previously been demonstrated (8, 9, 14, 15) . In our study the effect of IGF-II on chromaffin cell survival was additive with the effect of bFGF or NGF and the decline in cell number was fully prevented after the first 2-4 days of culture. IGF-II added with bFGF even reversed the decline to an increase in chromaffin cell number after 6 days due to stimulation of cell proliferation.
Chron-a-iMn Cell Proliferation in Vivo. Our observation that IGF-I and IGF-II are mitogens for fetal and neonatal rat chromaffin cells in vitro and act in synergy with NGF and bFGF may indicate that these factors are involved in the development of the adrenal medulla. Biosynthesis of IGF-I, IGF-II, NGF, or bFGF has not been demonstrated in the fetal or early neonatal adrenal medulla (6, 50, 51) , but the growth factors may originate from the circulation or innervation.
Immunoreactive bFGF appears at postnatal day 8 in an increasing fraction of rat chromaffin cells and is confined to the noradrenergic subpopulation of chromaffin cells in the adult rat (6) . In the adult bovine adrenal medulla, the majority of chromaffin cells are bFGF-immunoreactive (7) . IGF-II is synthesized by the adult human adrenal medulla (18) (19) (20) , but the expression is apparently confined to a subpopulation of 1-10% of the chromaffin cells (21) . Thus, IGF-II and bFGF may stimulate replacement of chromaffin cells in adult mammals in an autocrine or paracrine manner.
The scarcity of mitotic figures in adult rat chromaffin cells in vivo has led to the dogma that adult chromaffin cells are postmitotic (2) and more recent work has confirmed that adult rat chromaffin cells rarely divide in situ (3) (4) (5) . However, adult rat chromaffin cells are not irreversibly postmitotic as they reveal a growth potential comparable to that of neonatal chromaffin cells when exposed to the synergistic action of IGF-I or IGF-II and bFGF or NGF in culture. In a recent study, Tischler et al. (12) demonstrated that NGF is a potent inducer of proliferation and neuronal differentiation for adult rat chromaffin cells in vitro in agreement with our findings. The apparent postmitotic state of adult chromaffin cells in situ may be induced by inhibitory factors in the adrenal gland. Thus, corticosterone and pituitary adenylate cyclase-activating polypeptide 38 inhibit IGF-II-and bFGFstimulated growth of cultured neonatal and adult chromaffin cells from 75% to 95% (M.F., unpublished observation).
Implantation of Chromaffin Cells in Brain. Brain implants of chromaffin cells have been used as dopaminergic donors in patients with Parkinson disease, but the long-term benefit has been hampered by poor survival of the implanted cells (30, 31) . The approach has been abandoned and replaced by transplantation of human fetal ventral mesencephalic cells that seems to give better results (52, 53) . Administration of NGF to brain implants of chromaffin cells in experimental animals has led to improved cell survival (35, 36) . Based on our data a combination of IGFs, NGF, and bFGF may be more effective than each growth factor alone in improving the survival of the chromaffin cell implants. Thus, implantation of autologous adrenal medullary tissue in diseased human brain should be reconsidered as it may be advantageous over transplantation of heterologous fetal tissue regarding tissue accessibility, immunotolerance, and medical ethics.
